154 related articles for article (PubMed ID: 26704932)
41. Regulation of Soluble E-Cadherin Signaling in Non-Small-Cell Lung Cancer Cells by Nicotine, BDNF, and β-Adrenergic Receptor Ligands.
Ray R; Goel S; Al Khashali H; Darweesh B; Haddad B; Wozniak C; Ranzenberger R; Khalil J; Guthrie J; Heyl D; Evans HG
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760996
[TBL] [Abstract][Full Text] [Related]
42. How echinoccocosis affects potential cancer markers in plasma: galectin-3, sN-cadherin and sE-cadherin? A preliminary report.
Giebultowicz J; Polanska-Plachta M; Wroczynski P; Zaborowski P; Polanski JA
Diagn Pathol; 2012 Feb; 7():17. PubMed ID: 22340429
[TBL] [Abstract][Full Text] [Related]
43. Soluble E-cadherin: A marker of genital epithelial disruption.
Liu R; Armstrong E; Constable S; Buchanan LB; Mohammadi A; Galiwango RM; Huibner S; Perry MC; Prodger JL; Coburn B; Kaul R
Am J Reprod Immunol; 2023 Mar; 89(3):e13674. PubMed ID: 36593681
[TBL] [Abstract][Full Text] [Related]
44. The E-Cadherin Cleavage Associated to Pathogenic Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the Immune Response and Cancer Induction in Humans.
Devaux CA; Mezouar S; Mege JL
Front Microbiol; 2019; 10():2598. PubMed ID: 31781079
[TBL] [Abstract][Full Text] [Related]
45. Soluble cadherins as cancer biomarkers.
De Wever O; Derycke L; Hendrix A; De Meerleer G; Godeau F; Depypere H; Bracke M
Clin Exp Metastasis; 2007; 24(8):685-97. PubMed ID: 17952616
[TBL] [Abstract][Full Text] [Related]
46. Iron Overload Causes Alterations of E-Cadherin in the Liver.
Fujikura Y; Krijt J; Povýšil C; Mělková Z; Přikryl P; Vokurka M; Nečas E
Folia Biol (Praha); 2016; 62(3):95-102. PubMed ID: 27516188
[TBL] [Abstract][Full Text] [Related]
47. Soluble fragments of e-cadherin cell-adhesion molecule increase in urinary-excretion of cancer-patients, potentially indicating its shedding from epithelial tumor-cells.
Katayama M; Hirai S; Yasumoto M; Nishikawa K; Nagata S; Otsuka M; Kamihagi K; Kato I
Int J Oncol; 1994 Nov; 5(5):1049-57. PubMed ID: 21559679
[TBL] [Abstract][Full Text] [Related]
48. Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer".
Tomassetti A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806026
[TBL] [Abstract][Full Text] [Related]
49. Cadherins: The Superfamily Critically Involved in Breast Cancer.
Ashaie MA; Chowdhury EH
Curr Pharm Des; 2016; 22(5):616-38. PubMed ID: 26825466
[TBL] [Abstract][Full Text] [Related]
50. Soluble E-cadherin fragments increased in circulation of cancer patients.
Katayama M; Hirai S; Kamihagi K; Nakagawa K; Yasumoto M; Kato I
Br J Cancer; 1994 Mar; 69(3):580-5. PubMed ID: 8123491
[TBL] [Abstract][Full Text] [Related]
51. Cadherin tales: Regulation of cadherin function by endocytic membrane trafficking.
Cadwell CM; Su W; Kowalczyk AP
Traffic; 2016 Dec; 17(12):1262-1271. PubMed ID: 27624909
[TBL] [Abstract][Full Text] [Related]
52. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA Regulation of Human Breast Cancer Stem Cells.
Shimono Y; Mukohyama J; Nakamura S; Minami H
J Clin Med; 2015 Dec; 5(1):. PubMed ID: 26712794
[TBL] [Abstract][Full Text] [Related]
54. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.
Tang MKS; Yue PYK; Ip PP; Huang RL; Lai HC; Cheung ANY; Tse KY; Ngan HYS; Wong AST
Nat Commun; 2018 Jun; 9(1):2270. PubMed ID: 29891938
[TBL] [Abstract][Full Text] [Related]
55. E-cadherin: Its dysregulation in carcinogenesis and clinical implications.
Wong SHM; Fang CM; Chuah LH; Leong CO; Ngai SC
Crit Rev Oncol Hematol; 2018 Jan; 121():11-22. PubMed ID: 29279096
[TBL] [Abstract][Full Text] [Related]
56. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges.
Loh CY; Chai JY; Tang TF; Wong WF; Sethi G; Shanmugam MK; Chong PP; Looi CY
Cells; 2019 Sep; 8(10):. PubMed ID: 31547193
[TBL] [Abstract][Full Text] [Related]
57. E-cadherin in contact inhibition and cancer.
Mendonsa AM; Na TY; Gumbiner BM
Oncogene; 2018 Aug; 37(35):4769-4780. PubMed ID: 29780167
[TBL] [Abstract][Full Text] [Related]
58. A central role for cadherin signaling in cancer.
Kourtidis A; Lu R; Pence LJ; Anastasiadis PZ
Exp Cell Res; 2017 Sep; 358(1):78-85. PubMed ID: 28412244
[TBL] [Abstract][Full Text] [Related]
59. Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.
Bruner HC; Derksen PWB
Cold Spring Harb Perspect Biol; 2018 Mar; 10(3):. PubMed ID: 28507022
[TBL] [Abstract][Full Text] [Related]
60. E-cadherin is required for metastasis in multiple models of breast cancer.
Padmanaban V; Krol I; Suhail Y; Szczerba BM; Aceto N; Bader JS; Ewald AJ
Nature; 2019 Sep; 573(7774):439-444. PubMed ID: 31485072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
